Growth Metrics

Rigel Pharmaceuticals (RIGL) FCF Margin (2010 - 2026)

Rigel Pharmaceuticals' quarterly FCF Margin came in at 4.63% in Q1 2026, up 631.0% year-on-year from 0.63% in Q1 2025, and down 85.3% quarter-over-quarter from 31.51% in Q4 2025.

Rigel Pharmaceuticals has reported FCF Margin for 16 years, with the latest figure at 4.63% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin rose 631.0% year-over-year to 4.63%; the trailing twelve-month figure through Mar 2026 stood at 26.45% (up 894.0% YoY), and the FY2025 full-year result was 25.71%, up 817.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 4.63%, down from 31.51% in the prior quarter.
  • The five-year high for FCF Margin was 39.2% in Q3 2024, with the low at 154.53% in Q1 2022.
  • Average FCF Margin over 5 years is 9.96%, with a median of 1.67% recorded in 2025.
  • Year-over-year, FCF Margin slumped 25185 bps in 2022 and surged 13891 bps in 2023.
  • Tracing RIGL's FCF Margin over 5 years: stood at 42.87% in 2022, then surged by 59 bps to 17.43% in 2023, then soared by 244 bps to 25.14% in 2024, then advanced by 25 bps to 31.51% in 2025, then sank by 85 bps to 4.63% in 2026.
  • The last three FCF Margin figures came in at 4.63% (Q1 2026), 31.51% (Q4 2025), and 34.6% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 43.35%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.17%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn 4.63%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.63%
Dec 31, 2025 31.51%
Sep 30, 2025 34.60%
Jun 30, 2025 30.03%
Mar 31, 2025 -1.67%
Dec 31, 2024 25.14%
Sep 30, 2024 39.20%
Jun 30, 2024 0.82%
Mar 31, 2024 -16.97%
Dec 31, 2023 -17.43%
Sep 30, 2023 -4.83%
Jun 30, 2023 22.06%
Mar 31, 2023 -15.63%
Dec 31, 2022 -42.87%
Sep 30, 2022 -60.20%
Jun 30, 2022 -43.18%
Mar 31, 2022 -154.53%
Dec 31, 2021 -93.41%
Sep 30, 2021 -48.59%
Jun 30, 2021 208.67%
Mar 31, 2021 -24.72%
Dec 31, 2020 -87.13%
Sep 30, 2020 -107.00%
Jun 30, 2020 -87.35%
Mar 31, 2020 -6.64%
Dec 31, 2019 -66.62%
Sep 30, 2019 -71.88%
Jun 30, 2019 -161.10%
Mar 31, 2019 -7.49%
Dec 31, 2018 30.58%
Sep 30, 2018 -415.99%
Jun 30, 2018 -1,548.85%
Dec 31, 2017 440.86%
Sep 30, 2017 -1,962.89%
Mar 31, 2017 -580.44%
Dec 31, 2016 -415.67%
Sep 30, 2016 -606.99%
Jun 30, 2016 -217.12%
Mar 31, 2016 -452.20%
Dec 31, 2015 -163.18%
Sep 30, 2015 -75.13%
Jun 30, 2015 -351.45%
Mar 31, 2015 824.38%
Dec 31, 2013 -331.65%
Jun 30, 2013 -1,540.71%
Jun 30, 2012 -1,437.20%
Mar 31, 2012 -3,312.93%
Sep 30, 2011 -306.64%
Jun 30, 2011 -4,522.03%
Sep 30, 2010 -27.54%